Sequent Scientific Cash Flow Annual

Trade
BSE: 512529 | NSE: SEQUENT | ISIN: INE807F01027 | Sector: Biotechnology & Drugs
109.75 -0.45 (-0.41%)Updated : 24 May 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line -54.65-137.6653.39145.45
Depreciation/ Depletion 61.5455.6951.0950.60
Non- Cash Items 83.43165.0342.1933.38
Changesin Working Capital -59.73-66.26-114.60-114.68
Cashfrom Operating Activities 30.6016.8132.06114.75
Capital Expenditures -35.62-86.18-32.46-52.83
Other Investing Cash Flow Items Total 29.7021.22-63.1062.48
Cashfrom Investing Activities -5.92-64.96-95.579.65
Financing Cash Flow Items -45.42-35.87-17.89-22.74
Issuance( Retirement)of Debt Net 43.9868.1086.24-125.04
Cashfrom Financing Activities -1.4432.2367.26-138.75
Net Changein Cash 23.24-15.923.75-14.35
Cash Interest Paid 45.3535.5716.2122.75
Cash Taxes Paid 14.0614.6426.7743.79
Total Cash Dividends Paid -0.00-12.34-1.43
Issuance( Retirement)of Stock Net -0.0011.2510.45
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,516.65+24.45(1.64%)
1,389.40+15.45(1.12%)
3,625.95+39.80(1.11%)
2,867.40-35.05 (-1.21%)
1,321.90-15.80 (-1.18%)
HomeMarketsPremiumFor youGet App